BRAND NAME | COMPOSITION | MANUFACTURER | PACKING |
Procabazi | Cabazitaxel 60mg | Glenmark Pharmaceuticals Ltd. | 1 Vial & 1 Diluent |
Cabazitaxel is used to treat metastatic castration-resistant prostate cancer. It was first approved by the FDA on June 17, 2010.
Reviews
There are no reviews yet.